Use of next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in diverse solid tumor types: The Foundation Medicine (FMI) experience with 2,200+ clinical samples.
Vincent A. Miller
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Jeffrey S. Ross
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Research Funding - Foundation Medicine
Kai Wang
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Siraj M. Ali
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Geoff Otto
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
John Curran
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Norma Alonzo Palma
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Roman Yelensky
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Sean Downing
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Phil Stephens
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Doron Lipson
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Gary A. Palmer
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine